Anti-Ccr4 Monoclonal Antibody KW-0761 (Mogamulizumab) or Investigator's Choice in Subjects With Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma (ATL)
Retrovirology - United Kingdom
doi 10.1186/1742-4690-12-s1-p31
Full Text
Open PDFAbstract
Available in full text
Date
August 28, 2015
Authors
Publisher
Springer Science and Business Media LLC